Expanding Pharmacy Services to the Hemophilia Treatment Center

Author:

Charafi Lena1,Campanella Lauren1,Shay Blake1ORCID,Rabatin Abigail2,Hughes Adriana1,Kennerly-Shah Julie2

Affiliation:

1. BayCare Health Systems Inc., Tampa, FL, USA

2. The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA

Abstract

Background: Hemophilia treatment centers (HTC) are multidisciplinary clinics that serve as medical homes for patients with hemophilia and other bleeding or clotting disorders. Traditionally, hemophilia treatment center teams have included hematologists, social workers, nurse coordinators, physical therapists, and in some instances, other healthcare professionals. Objective: This report describes the role of clinical pharmacy services added at 2 HTCs. Method: Retrospective review of services provided by pharmacists integrated into the care team conducted at 2 HTCs. Conclusions: Pharmacists have the knowledge and training to positively contribute to the care of hemophilia treatment center patients. Specifically, with expertise in therapeutic drug monitoring, pharmacokinetics and patient counseling, pharmacists have the ability to manage the cost of care by promoting adherence, minimizing emergency department visits, and assisting providers in formulating optimal treatment plans to improve care for this patient population.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Pharmacology,Pharmacy

Reference12 articles.

1. CDC. What is hemophilia. Centers for Disease Control and Prevention. 2020. Accessed 19 January 2023. https://www.cdc.gov/ncbddd/hemophilia/facts.html

2. CDC. Hemophilia treatment centers (HTCs) [Internet]. Centers for Disease Control and Prevention. 2020. Accessed 11 March 2021. https://www.cdc.gov/ncbddd/hemophilia/HTC.html

3. CDC. Search directory. 2023. Accessed 19 January 2023. https://dbdgateway.cdc.gov/HTCDirSearch.aspx

4. Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia

5. Once‐weekly prophylactic treatment vs. on‐demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3